Kissei Pharmaceutical Co., Ltd.

This study tested a new drug, KLH-2109, in 89 premenopausal Japanese women with uterine fibroids who had heavy bleeding and pain. The drug was compared to a placebo to see if it could reduce bleeding and pain over 12 weeks. Results showed that KLH-2109 helped more women achieve n…

This study tested an experimental drug called MR13A9 in 247 adults on hemodialysis who had severe itching (uremic pruritus). The goal was to see if the drug safely reduces itch intensity compared to a placebo. Participants rated their worst daily itch on a 0-10 scale, and the mai…

This study tested a drug called MR13A9 in 178 adults on hemodialysis who had severe itching not caused by other conditions. Participants received either the drug or a placebo for 4 weeks, followed by an open-label phase to check long-term safety. The main goal was to see if MR13A…